Eye Drops Recall List 2026: Which Eye Drops Were Recalled, and How to Check Your Bottle
SafeRxPills Pharmacy Team
Editorial team at SafeRxPills. Articles are written and checked against regulatory drug labelling (DailyMed, FDA, EMA) and published literature.

How to Buy Eye Care Medicine Online Safely | SafeRxPills — pharmacy guide
In this article (23 sections)
Eye drops are meant to be sterile, and when a batch is not, or a factory cannot show that it is, the product gets recalled. 2026 has been a heavy year. FDA recall records list 18 recall events for eye medicines that began between January and October 2026, and 14 of them cite sterility. The biggest named products were Rohto Cooling Eye Drops in July, a group of dry eye drops and gels including GenTeal Tears gel, Systane Night Gel, iVIZIA, Oasis Tears PF, Optase and Freshkote in April, and several rounds of store-brand lubricant and redness drops sold under pharmacy and supermarket labels.
This page lists which eye drops have been recalled, from the 2023 EzriCare outbreak to October 2026, explains why contamination in eye drops is more dangerous than in most medicines, and shows how to check your own bottle by lot number and NDC. Every count comes from FDA and CDC pages or from the openFDA drug recall database, queried on 30 October 2026, all listed under Sources. Recall lists change weekly, so treat this as a starting point and check the FDA links for anything new. We sell eye care products, so we have a commercial interest; the note on that is at the end.
The short answer
If you have eye drops at home, find the lot number and expiry date (printed on the carton and usually on the bottle) and the product name. Search the FDA Enforcement Report or the FDA recalls page for the product name, then compare lot numbers. Most 2026 recalls cover specific lots, not every bottle with that brand name; a few cover "all lots" or "all unexpired lots".
If your lot is listed, stop using it and keep it out of reach until you return or discard it as the recall notice says. If you used a recalled product and have eye pain, discharge, redness, light sensitivity, blurred vision or a feeling that something is in your eye, CDC's advice for the 2023 outbreak was to seek medical care immediately. Those symptoms are a reason to see a doctor whatever the drops were.
Which eye drops have been recalled in 2026
The table lists every 2026 eye medicine recall event in the openFDA drug enforcement data as of its 21 October 2026 update. Dates are when the firm started the recall; FDA often posts the record two to six weeks later. All 2026 events in the table are Class II or Class III; none was Class I.
| Recall began | Recalling firm | Products | Reason in the record | Class |
|---|---|---|---|---|
| 3 Mar 2026 | K.C. Pharmaceuticals | Store-brand artificial tears, dry eye, redness and lubricating drops (Leader, Good Sense, Walgreens, GeriCare, TopCare and others), 8 entries, 3,111,072 bottles | Lack of assurance of sterility | II |
| 5 Mar 2026 | Apotex Corp. | Brimonidine and timolol 0.2%/0.5% (prescription), 2 lots | Lack of assurance of sterility | II |
| 25 Mar 2026 | Preferred Pharmaceuticals | Artificial tears (glycerin, hypromellose), 720 bottles | Lack of assurance of sterility | II |
| 17 Apr 2026 | Harrow Eye | Freshkote lubricant eye drops | Lack of assurance of sterility | II |
| 20 Apr 2026 | Scope Health | Optase Dry Eye Intense drops | Lack of assurance of sterility | II |
| 21 Apr 2026 | Alcon Research | GenTeal Tears Lubricant Eye Gel; Systane Night Gel | Lack of assurance of sterility (FDA inspection observations) | II |
| 23 Apr 2026 | Thea Pharma | iVIZIA and Similasan iVIZIA lubricant drops (povidone 0.5%) | Lack of assurance of sterility (CGMP deviations found at the manufacturer) | II |
| 27 Apr 2026 | Oasis Medical | Oasis Tears PF, 3 lots | Lack of assurance of sterility (FDA inspection of Excelvision) | II |
| 18 May 2026 | PReye | Vitamin See preservative-free drops, about 50 to 60 bottles | Lack of assurance of sterility | II |
| 18 May 2026 | AbbVie | Pred Mild (prednisolone acetate 0.12%) | Failed stability specifications | III |
| 4 Jun 2026 | Lupin Pharmaceuticals | Prednisolone acetate 1% suspension, 2,530,182 bottles | Presence of foreign substance | II |
| 14 Jul 2026 | Rohto-Mentholatum (Vietnam) | Rohto Cooling Eye Drops (Max Strength, Cool Relief, Digi Eye, Dry Aid and others), 8 entries | Lack of assurance of sterility | II |
| 22 Jul 2026 | Micro Labs USA | Dorzolamide and timolol 2%/0.5% (prescription) | Defective container (broken cap spikes) | II |
| 20 Aug 2026 | Sterling Pharmaceutical Services | Lubricant drops sold as TRP Gentle Eyes, AvKare, Walgreens, Cameron and Reliable-1, 8 entries | Lack of assurance of sterility | II |
| 24 Aug 2026 | ImprimisRx | Povidone iodine 1.25% and proparacaine 0.5% (compounded) | Subpotent drug | III |
| 11 Sep 2026 | K.C. Pharmaceuticals | Store-brand dry eye, advanced relief and redness drops (Leader, Crocodile Tears, Discount Drug Mart, Best Choice, Equaline and others), 8 entries | Lack of assurance of sterility | II |
| 15 Sep 2026 | Insight Pharmaceuticals (Prestige) | Clear Eyes Redness Relief (glycerin, naphazoline) | Lack of assurance of sterility | II |
| 17 Sep 2026 | Aurolab Trust | FOCUS PI hypromellose 0.7%, 25,220 bottles | Lack of assurance of sterility | II |
"Lack of assurance of sterility" does not mean bacteria were found in the bottles. It means FDA or the company decided the manufacturing conditions could not support the claim that the product is sterile. In the 2023 EzriCare recall, by contrast, FDA testing found bacteria in unopened bottles, and in the Kilitch store-brand recall FDA found bacteria in samples from the factory; both were Class I.
What drove the 2026 spikes in searches
Google Ads data for the US shows 1,000 to 1,600 monthly searches for "eye drops recall" from October 2025 to February 2026 and 4,400 in March, then 301,000 in April 2026 and 135,000 in each of July and August 2026, falling to 9,900 in September. The recall records line up with those months. The K.C. Pharmaceuticals store-brand recall started in March and was posted on 8 April, and five firms started recalls of six dry eye drops and gels between 17 and 27 April. In July, Rohto-Mentholatum recalled its Cooling Eye Drops range, the largest 2026 recall by quantity. The Sterling recall began on 20 August. Search data cannot prove why people searched, but those are the recalls that were live when the numbers jumped.
The April 2026 Excelvision recalls
FDA inspected the Excelvision drug plant in Annonay, France, from 12 to 19 November 2024 and sent the company a warning letter on 7 May 2025. The letter describes "the presence of mold, black specks, and discoloration" in drug products, a "documented history of mold recovery in the aseptic filling lines" and water leaks in the compounding room, and says this "compromises the sterility and safety of your drug products."
In April 2026 several US distributors recalled dry eye products. The Oasis Tears PF record says the recall followed "FDA observations noted during a recent inspection of Excelvision". The iVIZIA record cites "CGMP deviations found by the FDA during an inspection of the manufacturer", and the Alcon records cite "FDA inspection observations". The Sjögren's Foundation grouped all of them as Excelvision-made and noted that "these recalls apply only to specific products and lots manufactured by Excelvision, not to all products sold under these brands."
| Product (US distributor) | Lots in the FDA record |
|---|---|
| GenTeal Tears Lubricant Eye Gel 10 g (Alcon), NDC 0065-8064-01 | 9T20, 9T50, 9T59, 1U30, 1U48, 4V15, 7V61, 1W47, 1W49, 1X14 |
| Systane Night Gel 10 g (Alcon), NDC 0065-0474-01 | 9T21, 1U63, 2U47, 6V00, 6V12, 8V54, 9V55, 8V58, 9V39, 9V97, 1W39, 1W40 and others listed |
| iVIZIA lubricant drops 10 mL (Thea), NDC 59262-700-11 and 82584-700-11 | 5S30B, 5S30C, 5S31B, 6S57B, 3T36B |
| Oasis Tears PF 10 mL (Oasis Medical), NDC 42126-6400-1 | 1V59, 3V12, 3V69 |
| Optase Dry Eye Intense (Scope Health), NDC 72972-002-01 | 8T98, 9T31, 9T32, 2V13, 2V14, 2V15, 3V35, 3V36, 3V37, 5V45 and others listed |
| Freshkote lubricant drops 10 mL (Harrow Eye) | 1X68, 1X69 |
Lot lists are cut short here where the record runs long. Check the full record on the FDA Enforcement Report before deciding a bottle is not affected.
Rohto Cooling Eye Drops, July 2026
Rohto-Mentholatum (Vietnam) started a voluntary nationwide recall on 14 July 2026, posted by FDA on 29 July. The eight entries cover Rohto Cooling Eye Drops sold as Max Strength (single and twin packs), Cool Relief, Digi Eye, Dry Aid and others, distributed by The Mentholatum Company and labelled "Made in Vietnam". The reason given is lack of assurance of sterility. The quantities listed across the eight entries add up to about 12 million cartons, the largest stated quantity of any 2026 eye drop recall in the records. Lots run across expiry dates from 2025 to 2029, so compare the lot code on your carton with the FDA record rather than going by the expiry date.
Store-brand lubricant and redness drops
Several 2026 recalls involve drops made by one contract manufacturer and sold under many store names. K.C. Pharmaceuticals recalled eight product lines in March 2026 (3,111,072 bottles) and eight more in September 2026 (the seven entries with a stated quantity total 4,848,342 cartons). The brand names on the cartons include Leader (Cardinal Health), Good Sense (Perrigo), Walgreens, GeriCare, TopCare, Harris Teeter, Good Neighbor Pharmacy, Crocodile Tears, Discount Drug Mart, Best Choice and Equaline. In August 2026 Sterling Pharmaceutical Services recalled lubricant drops sold as TRP Gentle Eyes, AvKare, Walgreens twin packs, Cameron and Reliable-1.
The practical point: the brand on the box may be your pharmacy's or supermarket's own label, not the maker's name. Search the recall records by the store brand and the product name, and use the NDC on the carton to be sure.
Counterfeit eye drops found in US stores, October 2026
On 16 October 2026 FDA warned that counterfeit versions of over-the-counter eye drops had been found in Florida and Georgia "in stores serving primarily Spanish-speaking customers" and may also be in Louisiana, Mississippi, North Carolina and other states. FDA said "several of these products have tested positive for bacterial contamination." The fakes copy Colirio Ocusan, Ocusan Dry Eyes, Colirio Manzanill A+ and Manzanilla Sophia products. FDA's comparison lists the giveaways: Spanish-only cartons, no Drug Facts panel, nothing printed on the bottom of the carton, an expiry date of 12/2030 or 10/2030, and different cap colours from the real product.
This is not a recall, because the counterfeiters are not recalling anything. It is a reminder that a recall search only covers legitimate products. Earlier, in January 2024, FDA warned about copycat versions of Lumify sold online as South Moon, Rebright and FivFivGo; FDA's testing found South Moon contaminated with Burkholderia cepacia complex and found that both tested products lacked brimonidine, the active ingredient in Lumify.
Recalls in 2024 and 2025
| Recall began | Firm and product | Reason in the record | Class |
|---|---|---|---|
| 18 Dec 2024 | Alcon: Systane Ultra PF single-use vials, lot 10101, 55,960 boxes of 25 | Non-sterility | I |
| 23 Apr 2025 | BRS Analytical Services: AvKARE artificial tears, lubricant gel and lubricant drops, 5 entries | CGMP deviations and lack of assurance of sterility | II |
| 28 May 2025 | Apotex: ketorolac 0.5%, azelastine 0.05% and brimonidine/timolol 0.2%/0.5% (prescription) | Lack of assurance of sterility | II |
| 5 Sep 2025 | Apotex: brimonidine and timolol; ketorolac 0.5% (prescription) | Improper bottle sealing leading to potential sterility concerns | II |
| 2024 to 2025, repeated | FDC Limited: timolol 0.25% and 0.5%, ciprofloxacin 0.3% (prescription) | Defective container: cap spike lodged in the nozzle | II |
| 31 Dec 2025 | Wizcure Pharmaa: Vista Tears, Vista Gel, Vista Gonio, BioGlo fluorescein strips and others, 7 entries, all lots | Lack of assurance of sterility (not made under current good manufacturing practice) | II |
The cap spike recalls are a different kind of problem. The spike inside the cap is meant to pierce the bottle tip; when it breaks off and lodges in the nozzle, patients cannot get the drops out. That is a missed-dose risk for glaucoma drops rather than an infection risk.
The 2023 EzriCare and Delsam artificial tears outbreak
In early 2023 CDC and FDA linked a multistate outbreak of an extensively drug-resistant Pseudomonas aeruginosa to artificial tears. The strain, VIM-GES-CRPA, "had never been reported in the United States prior to this outbreak." Global Pharma Healthcare of Chennai, India, recalled EzriCare Artificial Tears and Delsam Pharma Artificial Tears on 2 February 2023, and Delsam Pharma Artificial Eye Ointment later that month. The FDA record for the drops says "FDA analysis found unopened products to have bacterial contamination," and the recall was Class I.
| CDC count as of 15 May 2023 | Number |
|---|---|
| Patients with the outbreak strain | 81, in 18 states |
| Patients with vision loss | 14 |
| Additional patients with enucleation (eyeball surgically removed) | 4 |
| Deaths within 30 days of a positive clinical culture | 4 |
| Specimens from eye sites (such as cornea or vitreous) | 21 |
| Specimen collection dates | May 2022 to April 2023 |
CDC reported that patients named more than 10 brands of artificial tears, but EzriCare, "a preservative-free, over-the-counter product packaged in multidose bottles, was the brand most commonly reported" and was "the only common artificial tears product identified across the four healthcare facility clusters." CDC found the outbreak strain in opened EzriCare bottles from multiple lots. Isolates tested at public health laboratories were not susceptible to a long list of antibiotics, including carbapenems, fluoroquinolones and tobramycin, which is why the infections were hard to treat.
FDA's October 2023 warning on 26 store-brand eye drops
On 27 October 2023 FDA warned consumers "not to purchase and to immediately stop using 26 over-the-counter eye drop products" because of "the potential risk of eye infections that could result in partial vision loss or blindness." FDA said its investigators had found "insanitary conditions in the manufacturing facility and positive bacterial test results from environmental sampling of critical drug production areas." The maker, Kilitch Healthcare India Limited, recalled the products in November 2023. FDA added a Walmart product on 30 October and a sixth Leader product on 3 November, so the final list has 28 rows.
| Brand on the FDA list | Products listed |
|---|---|
| CVS Health | 9 |
| Leader (Cardinal Health) | 6 |
| Rite Aid | 6 |
| Target Up&Up | 3 |
| Rugby (Harvard Drug Group) | 2 |
| Velocity Pharma | 1 |
| Walmart Equate | 1 |
FDA said at the time it had not received adverse event reports of eye infection linked to these products. The list dates from 2023, but it shows how one factory can sit behind many retail brands.
How often eye medicines are recalled
We pulled every FDA drug recall record for eye products from the openFDA enforcement database on 30 October 2026 (728 records, data updated 21 October 2026) and grouped them into recall events, because one event can cover many products or lots. An event is counted under sterility if any product in it cited sterility or non-sterility.
| Year recall began | Events citing sterility | Events for other reasons | Total events |
|---|---|---|---|
| 2019 | 16 | 18 | 34 |
| 2020 | 3 | 8 | 11 |
| 2021 | 7 | 7 | 14 |
| 2022 | 6 | 14 | 20 |
| 2023 | 9 | 12 | 21 |
| 2024 | 8 | 14 | 22 |
| 2025 | 4 | 10 | 14 |
| 2026 (to 21 Oct) | 14 | 4 | 18 |
Across 2022 to October 2026 there were 95 events. Sterility was the most common reason.
| Main reason, 2022 to Oct 2026 | Events |
|---|---|
| Sterility or non-sterility | 41 |
| Failed quality, impurity, stability or potency test | 27 |
| Defective container | 14 |
| Manufacturing (CGMP) deviations without a sterility statement | 10 |
| Other reasons | 2 |
| Labeling | 1 |
Method notes: we matched records whose product description mentions ophthalmic use, eye drops, eye gel, eye ointment, artificial tears or lubricant eye products, or whose openFDA route is ophthalmic, and removed two records that were not eye products. The grouping of reasons is ours, made from the free-text reason in each record. openFDA itself warns users not to rely on it for medical decisions and to assume results are unvalidated, so use these counts as a picture of the trend, not an official tally.
Why contamination in eye drops is so dangerous
FDA's eye drop safety page puts it plainly: "Ophthalmic drug products, such as eye drops, pose a heightened risk of harm to users because drugs applied to the eyes bypass some of the body's natural defenses. Any drug used in the eyes must be sterile to reduce the risk of infection." During the 2023 outbreak CDC asked doctors treating keratitis (infection of the cornea) or endophthalmitis (infection inside the eye) to ask patients whether they had used the recalled products. The outcomes CDC counted show the range of harm: vision loss, surgical removal of the eye and deaths.
The same FDA page says preservatives help prevent microbial contamination and extend shelf life, "especially eye drop products in multi-dose containers." EzriCare was a preservative-free product in a multidose bottle. Single-use vials avoid the problem of repeated opening, though the 2024 Systane Ultra PF recall shows that vials can also be recalled when a batch is not sterile.
What Class I, II and III mean
| Class | FDA definition |
|---|---|
| Class I | "a reasonable probability that the use of, or exposure to, a violative product will cause serious adverse health consequences or death" |
| Class II | "may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote" |
| Class III | "not likely to cause adverse health consequences" |
The class is FDA's view of the hazard, assigned after the firm starts the recall. A Class II recall for sterility still means you should stop using that lot. The class tells you how serious FDA thinks the risk is, not whether to keep using the product.
How to check whether your bottle is recalled
- Find the product name, the store brand if there is one, the NDC (a code in three parts, such as 0065-8064-01, on the carton and often on the bottle) and the lot number and expiry date.
- Search the FDA Enforcement Report for the product name or firm. This is the most complete list and includes recalls that never got a press release.
- Check the FDA recalls, market withdrawals and safety alerts page. FDA notes that "Not all recalls have press releases or are posted on this page," which is why step 2 matters.
- Read FDA's What You Should Know about Eye Drops page, which links current alerts, including the October 2026 counterfeit warning.
- Compare the lot number exactly. A recall that lists specific lots does not cover other lots of the same product. A recall that says "all lots" or "all unexpired lots" covers every bottle within date.
- If the lot matches, follow the recall notice: most tell you to stop using the product and return it to the place of purchase or discard it.
If you bought eye drops outside the US, a US recall covers US-distributed lots with US NDCs. In India, CDSCO publishes a monthly Not of Standard Quality (NSQ) alert: "drug samples are picked from sales/distribution point, analyzed and list of Not of Standard Quality (NSQ) drugs are displayed on CDSCO portal on monthly basis." Those lists name the product, batch number, maker and the test it failed.
Symptoms that mean stop and see a doctor
CDC listed these eye infection symptoms for people who had used the recalled 2023 products:
- Yellow, green or clear discharge from the eye
- Eye pain or discomfort
- Redness of the eye or eyelid
- Feeling of something in your eye (foreign body sensation)
- Increased sensitivity to light
- Blurry vision
CDC's advice was that people who used the recalled products and had signs of an eye infection "should seek medical care immediately." The standard US over-the-counter label on lubricant drops also says to stop use and ask a doctor "if you experience eye pain, changes in vision, continued redness or irritation of the eye, or if the condition worsens or persists for more than 72 hours." Keep the bottle and carton, because the lot number helps your doctor and the health department.
Buying eye drops more safely
- Check the seal. The US Refresh Tears label says "Use only if tape seals on top and bottom flaps are intact." Do not use a bottle with a broken carton seal or a missing tamper band on the cap; a missing tamper evidence seal on the outer container was the reason given for a 2023 travoprost recall (Golden State Medical Supply).
- Look for a Drug Facts panel in English on US over-the-counter products, a lot number and an expiry date. FDA's counterfeit guide lists a missing Drug Facts panel and a blank carton bottom as signs of fakes.
- Be wary of eye drops sold with claims to treat glaucoma, cataracts or "floaters" without a prescription. FDA said the copycat Lumify products "claim to treat eye conditions such as glaucoma, which is treated with prescription drugs or surgery."
- FDA "recommends consumers only buy eye products from reputable retailers such as state-licensed pharmacies and beware of online retailers selling products with false claims."
- For prescription eye drops (glaucoma, steroid, antibiotic or cyclosporine drops), use the product and strength your eye doctor prescribed. Our guide to prescription eye drops from an online pharmacy covers that side in more detail. Glaucoma drops and guides are grouped on our glaucoma page.
Using and storing eye drops to cut contamination risk
- Do not let the tip touch anything, including your eye, eyelashes and fingers. The Refresh Tears label: "To avoid contamination, do not touch tip of container to any surface. Replace cap after using."
- Do not use drops that have changed colour or gone cloudy. The same label says: "If solution changes color or becomes cloudy, do not use."
- Do not share drops with anyone, and do not decant them into another bottle.
- Single-use vials are for one use. The Refresh Plus label says "Do not reuse. Once opened, discard."
- Keep drops at the storage temperature on the carton; the Refresh labels say 59° to 77°F (15° to 25°C).
- If you use more than one kind of drop, ask your pharmacist how long to wait between them, and keep each cap on its own bottle.
Discard dates after opening
The expiry date on the carton applies to an unopened bottle. Many multidose drops also have a use-within period after opening, printed on the carton or leaflet. For example:
| US label (DailyMed) | Container | After opening |
|---|---|---|
| Refresh Tears (Allergan), carboxymethylcellulose | Multidose bottle with preservative | "Discard 90 days after opening" |
| Refresh Plus (Allergan), carboxymethylcellulose | Single-use vial, preservative-free | "Once opened, discard" |
Other products, and the same brand sold in other countries, can have different periods. Go by the carton you have, and write the date you opened the bottle on the label.
Buying eye medicines online: what FDA says
FDA's consumer page on online pharmacies warns that "there are many unsafe online pharmacies that claim to sell prescription drugs at deeply discounted prices, often without requiring a prescription," and that "these drugs could be fake, expired or otherwise unsafe." It also notes that some unsafe sellers' drugs "may not have been stored properly, such as in a warehouse without necessary temperature controls."
FDA's BeSafeRx campaign "helps consumers learn about how to safely buy prescription medicines online," and the FDA consumer page says to "check the pharmacy's license in the state's board of pharmacy license database by using the location tool on the FDA's BeSafeRx website. If your online pharmacy is not listed, don't use that pharmacy." Our general guides on buying medicine online safely and verifying an online pharmacy go through those checks step by step.
Whoever you buy from, the same bottle checks apply: an intact seal, a lot number and expiry you can look up, and storage instructions you can follow at home.
Import rules
Eye drops made for the Indian market are not FDA approved products. The FDA's personal importation page says: "In most circumstances, it is illegal for individuals to import drugs or devices into the U.S. for personal use because these products purchased from other countries often have not been approved by the FDA for use and sale in the U.S." Rules differ by country and change, so check your own situation with the regulator where you live and with your eye doctor before ordering.
Related eye care guides
- Glaucoma eye drops: every type compared
- Latanoprost eye drops: side effects, use and storage
- Lumigan eye drops for glaucoma
- Cyclosporine eye drops for dry eye
- Prescription eye drops from an online pharmacy
Where SafeRxPills fits
We sell Indian-market eye care products, and we make no claim that they are safer or tested differently from anything else on the market. US recall records cover US-distributed products and lots. Several makers and brand families whose Indian products we list also appear in US recall records for other products or for US packs, including FDC Limited (timolol and ciprofloxacin drops, cap spike defects, 2024 to 2025), Micro Labs USA (dorzolamide and timolol, July 2026), Sun Pharma (Cequa cyclosporine vials, 2021 to 2023) and the US Refresh range (Refresh P.M. and Lacri-Lube ointments, AbbVie, September 2024). Those records do not tell you anything, good or bad, about a particular Indian batch. Check the seal, lot and expiry on anything you receive, from us or anyone else. Prices as of 30 October 2026, before shipping:
| Product | Contains | Smallest pack listed |
|---|---|---|
| Refresh Tear (Allergan India), 10 mL | Carboxymethylcellulose sodium | 3 bottles, $20.00 ($6.67 each) |
| Moisol Eye Drop (FDC Ltd), 5 mL | Hydroxypropylmethylcellulose | 3 bottles, $15.00 ($5.00 each) |
| Trehalube Eye Drop (Micro Labs), 10 mL | Sodium hyaluronate based | 1 bottle, $20.00 |
| Cyclomune 0.05% Eye Drop (Sun Pharma), 3 mL | Cyclosporine (prescription medicine) | 1 bottle, $17.00 |
The discard-after-opening period for these Indian packs is on each carton and leaflet; follow that, not the US label periods above. Cyclosporine drops are a prescription medicine; use them only on an eye doctor's advice.
Sources
- openFDA drug enforcement API, api.fda.gov/drug/enforcement.json, queried 30 October 2026 (data last updated 21 October 2026); search on product description terms ophthalmic, opthalmic, eye drop(s), eyedrop(s), eye gel, eye ointment, artificial tears, lubricant eye, or openfda.route OPHTHALMIC; 728 records. openFDA
- Centers for Disease Control and Prevention. Outbreak of Extensively Drug-resistant Pseudomonas aeruginosa Associated with Artificial Tears, update as of 15 May 2023 (archived). CDC
- US Food and Drug Administration. FDA warns consumers not to purchase or use certain eye drops from several major brands due to risk of eye infection, 27 October 2023, updated to 15 November 2023. FDA
- US Food and Drug Administration. What You Should Know about Eye Drops, content current as of 16 October 2026. FDA
- US Food and Drug Administration. Counterfeit Versions of Eye Drops Found in Several States, 16 October 2026. FDA
- US Food and Drug Administration. FDA warns consumers of contaminated copycat eye drops, 31 January 2024. FDA
- US Food and Drug Administration. Warning Letter 320-25-70 to Excelvision Fareva, 7 May 2025. FDA
- Sjögren's Foundation. FDA Recall: Several lots of major eye drop brands manufactured by Excelvision, 2026. Sjögren's Foundation
- US Food and Drug Administration. Enforcement Report Information and Definitions. FDA
- US Food and Drug Administration. Recalls, Market Withdrawals, and Safety Alerts, content current as of 27 October 2026. FDA
- Refresh Tears (carboxymethylcellulose sodium) drops, Drug Facts, Allergan, DailyMed setid 329d1fe0-4432-4565-b7b1-65666bd86526, published 26 October 2026. DailyMed
- Refresh Plus (carboxymethylcellulose sodium) single-use drops, Drug Facts, Allergan, DailyMed setid 0f6a4b4b-cde6-4518-84b5-ce997f1154a7. DailyMed
- US Food and Drug Administration. How to Buy Medicines Safely From an Online Pharmacy, content current as of 2 January 2025. FDA
- US Food and Drug Administration. BeSafeRx: Your Source for Online Pharmacy Information. FDA
- US Food and Drug Administration. Personal Importation. FDA
- Central Drugs Standard Control Organisation (India). Not of Standard Quality (NSQ) Alert for the month of March 2025. CDSCO
- Google Ads search volume for "eye drops recall", United States, October 2025 to September 2026, via DataForSEO, retrieved 30 October 2026.
This page is for information and is not medical advice. If you have eye pain, discharge or a change in vision, see a doctor promptly.
?Frequently Asked Questions
Which eye drops have been recalled in 2026?
FDA recall records list 18 recall events for eye medicines that began between January and 21 October 2026. They include Rohto Cooling Eye Drops (July), GenTeal Tears Lubricant Eye Gel, Systane Night Gel, iVIZIA, Oasis Tears PF, Optase Dry Eye Intense and Freshkote (April), Clear Eyes Redness Relief (September), and store-brand lubricant and redness drops from K.C. Pharmaceuticals (March and September) and Sterling Pharmaceutical Services (August). Fourteen of the 18 events cite lack of assurance of sterility.
Why were so many eye drops recalled in April 2026?
Five US distributors recalled six dry eye drops and gels between 17 and 27 April 2026. The Oasis Tears PF record says the recall followed FDA observations during an inspection of Excelvision, a plant in Annonay, France, and the iVIZIA and Alcon records cite FDA inspection findings at the manufacturer. FDA's May 2025 warning letter to Excelvision described mold in drug products and a history of mold recovery in the aseptic filling lines.
Were Rohto eye drops recalled?
Yes. Rohto-Mentholatum (Vietnam) started a voluntary nationwide recall of Rohto Cooling Eye Drops on 14 July 2026 for lack of assurance of sterility. The eight entries include Max Strength, Cool Relief, Digi Eye and Dry Aid, and the quantities listed add up to about 12 million cartons. Compare the lot code on your carton with the FDA Enforcement Report.
How do I know if my eye drops are recalled?
Find the product name, store brand, NDC and lot number on the carton. Search the FDA Enforcement Report and the FDA recalls page for the product, then compare the lot number exactly. Most recalls list specific lots; some cover all lots or all unexpired lots. If your lot matches, stop using it and follow the recall notice.
What happened with EzriCare artificial tears?
In 2023 CDC linked EzriCare Artificial Tears to an outbreak of an extensively drug-resistant Pseudomonas aeruginosa strain. As of 15 May 2023 CDC counted 81 patients in 18 states, 14 with vision loss, an additional 4 who had an eyeball surgically removed, and 4 deaths within 30 days. The maker, Global Pharma of Chennai, India, recalled EzriCare Artificial Tears and Delsam Pharma Artificial Tears on 2 February 2023, and Delsam Pharma Artificial Eye Ointment later that month. FDA found bacteria in unopened EzriCare bottles.
What were the 26 eye drops FDA warned about in 2023?
On 27 October 2023 FDA told consumers to stop using 26 over-the-counter eye drops sold under CVS Health, Leader, Rite Aid, Target Up&Up, Rugby and Velocity brands, after finding insanitary conditions and positive bacterial tests at the factory. FDA later added a Walmart Equate product and a sixth Leader product, giving 28 rows. The maker, Kilitch Healthcare India Limited, recalled them in November 2023.
What does lack of assurance of sterility mean?
It means FDA or the company concluded that manufacturing conditions could not support the claim that the product is sterile. It does not by itself mean bacteria were found in the bottles. Because eye drops must be sterile, a lot recalled for this reason should not be used.
What symptoms after using eye drops mean I should see a doctor?
CDC listed yellow, green or clear discharge, eye pain or discomfort, redness of the eye or eyelid, a feeling of something in the eye, increased sensitivity to light and blurry vision. CDC advised people with these signs after using the recalled 2023 products to seek medical care immediately. Keep the bottle and carton so the lot number can be checked.
Are preservative-free eye drops more likely to be contaminated?
FDA says preservatives help prevent microbial contamination, especially in multi-dose containers. EzriCare was a preservative-free product in a multidose bottle. Single-use vials avoid repeated opening and are meant to be thrown away after one use, though a single-use product can still be recalled if a batch is not sterile, as Systane Ultra PF vials were in December 2024.
How long can I use eye drops after opening?
Go by the carton or leaflet of the product you have. The US Refresh Tears label says to discard the bottle 90 days after opening, and the US Refresh Plus single-use vials say to discard once opened. Other products and the same brand in other countries can differ. Do not use drops that have changed colour or turned cloudy.
Are there counterfeit eye drops in the US?
Yes. On 16 October 2026 FDA warned that counterfeit over-the-counter eye drops copying Ocusan, Manzanill A+ and Manzanilla Sophia products had been found in Florida and Georgia and may be in other states, and that several tested positive for bacteria. Signs include Spanish-only cartons, no Drug Facts panel, a blank carton bottom and an expiry date of 12/2030 or 10/2030.
SafeRxPills Pharmacy Team
Pharmacist, Content, B.Pharm, M.Pharm, Rajiv Gandhi University
Pharmacist writing on antiparasitic, ophthalmic and dermatological generics. Focuses on what the regulatory labelling and published evidence actually support.
Comments (0)
Leave a Comment
No comments yet. Be the first to share your thoughts!
Related Articles


Tobramycin Eye Drops and Tobradex: Dosage, Side Effects, Steroid Warnings and US Cost
November 4, 2026

Moxifloxacin Eye Drops (Vigamox): Dosage, Side Effects, Babies, Ointment and US Cost
November 3, 2026
